DEERFIELD, Ill., APRIL 24, 2013 - Baxter International Inc. (NYSE: BAX) will webcast its annual meeting of shareholders on Tuesday, May 7, 2013, at 9:00 a.m. Central Time.
This meeting is being webcast by Thomson Reuters and can be accessed along with accompanying slides from Baxter's Web site at www.baxter.com. The meeting will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission.
Baxter International Inc. innovates, develops, manufactures and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company's diverse portfolio is focused on treatments that save and sustain lives. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to research and create products that advance patient care worldwide.